List of 3 HealthTech Venture Capital investors in Asia [2022]

healthcare VC

This article directly stems from the research process for our global venture capital investors database. Based on this list and our advanced keyword crawler technology, we created a list of venture capital investors that mention healthtech-related keywords on their website. The list – offered as an Excel file – is perfectly suited to get in touch with the most relevant investors in the field.

Icons Thousandinvestors

This article offers an insight into three interesting startup investors in Asia from our keyword crawler based global healthtech VC investor list.

1. Atinum Investment (South Korea)

Atinum is a leading VC firm that invests in startups in the growth stage of driving market and technology innovations. They manage 26 funds and have funded 425 companies. Their portfolio consist of various sectors such as software, SaaS, games, material, tech, biotech and medical devices as well as services. A promising portfolio company is Skylabs, who have developed a heart rate monitoring device that can be worn as a ring.

2. Vertex Ventures SEA & India (Singapore)

Vertex Ventures is a well-connected venture capital company that focuses on technology startups in Southeast Asia and India. Their portfolio focuses on consumers, enterprise, fintech, sustainability, and healthtech. A digital health platform in their portfolio is Proactive For Her. They focus on providing accessible, personalized and confidential healthcare for women in India.

3. DG Daiwa Ventures (Japan)

DG Daiwa Ventures is a VC that invests in startups in the technology sector. They also provide businesses with developmental support. The company is especially interested in blockchain, security, AI, and biohealth. A portfolio company they are supporting is helium health, a software that enables the digitalization of patient information for people in Africa. Another company is Happiest Baby, an American business that developed an intelligent crib for babies.

Picture Source: Julia Zyablova

Leave a Reply

Your email address will not be published. Required fields are marked *

Thousand Investors